AEYE Health

AEYE Health
AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.
About
Technology stack
detected 2026-07-13No comments yet. Be the first to share your take.
What does AEYE Health do?
AEYE Health provides FDA-cleared, autonomous AI diagnostic screening solutions for diabetic retinopathy. Their AEYE-DS product offers instant, on-the-spot diagnosis using portable or tabletop cameras, enabling primary care physicians to screen patients at the point of care.
How much funding has AEYE Health raised?
AEYE Health has raised a total of $4M in funding. The most recent round on record is Seed.
Where is AEYE Health headquartered?
AEYE Health is headquartered in Tel Aviv, Israel.
When was AEYE Health founded?
AEYE Health was founded in 2016.
What industry does AEYE Health operate in?
AEYE Health operates in Healthcare, Optometry, Retinal Screening Ophthalmology, Diabetic Retinopathy, Diabetes, HealthTech.
How many employees does AEYE Health have?
AEYE Health has approximately 39 people on record.
What is AEYE Health's revenue?
StartupHub estimates AEYE Health's annual revenue at $13.2M (range $7.2M to $22.0M, 63% confidence), based on comparable companies in the sector.
What is AEYE Health's valuation?
StartupHub estimates AEYE Health's effective valuation at $16.3M (range $10.0M to $24.0M, 10% confidence), based on comparable companies in the sector.